[go: up one dir, main page]

DD215549A5 - Verfahren zur herstellung neuer 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxide - Google Patents

Verfahren zur herstellung neuer 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxide Download PDF

Info

Publication number
DD215549A5
DD215549A5 DD83255478A DD25547883A DD215549A5 DD 215549 A5 DD215549 A5 DD 215549A5 DD 83255478 A DD83255478 A DD 83255478A DD 25547883 A DD25547883 A DD 25547883A DD 215549 A5 DD215549 A5 DD 215549A5
Authority
DD
German Democratic Republic
Prior art keywords
group
hydroxy
dioxide
methyl
carboxamide
Prior art date
Application number
DD83255478A
Other languages
German (de)
English (en)
Inventor
Guenter Trummlitz
Wolfhard Engel
Ernst Seeger
Walter Haarmann
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of DD215549A5 publication Critical patent/DD215549A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DD83255478A 1982-10-09 1983-10-06 Verfahren zur herstellung neuer 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxide DD215549A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823237473 DE3237473A1 (de) 1982-10-09 1982-10-09 Neue 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung, ihre verwendung und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
DD215549A5 true DD215549A5 (de) 1984-11-14

Family

ID=6175330

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83255478A DD215549A5 (de) 1982-10-09 1983-10-06 Verfahren zur herstellung neuer 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxide

Country Status (24)

Country Link
US (1) US4533664A (es)
EP (1) EP0106214B1 (es)
JP (1) JPS5988482A (es)
KR (1) KR840006634A (es)
AT (1) ATE16807T1 (es)
AU (1) AU1998683A (es)
CA (1) CA1207767A (es)
CS (1) CS236896B2 (es)
DD (1) DD215549A5 (es)
DE (2) DE3237473A1 (es)
DK (1) DK460783A (es)
ES (2) ES8501393A1 (es)
FI (1) FI833566A (es)
GB (1) GB2128190B (es)
GR (1) GR79010B (es)
HU (1) HU190169B (es)
IL (1) IL69931A (es)
NO (1) NO833665L (es)
NZ (1) NZ205891A (es)
PH (1) PH20402A (es)
PL (1) PL139147B1 (es)
PT (1) PT77466B (es)
SU (1) SU1148565A3 (es)
ZA (1) ZA837500B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3435843A1 (de) * 1984-09-29 1986-04-03 Gödecke AG, 1000 Berlin Antirheumatisch wirksame suppositorien
US5599811A (en) * 1995-02-21 1997-02-04 Warner-Lambert Company Benzothiazine dioxides as endothelin antagonists
WO2023154412A1 (en) * 2022-02-12 2023-08-17 Miralogx Llc Anti-inflammatory compounds, pharmaceutical compositions, and treatment methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US3891637A (en) * 1974-10-01 1975-06-24 Pfizer Process for the production of carboxamides of oxo-1,2-benzothiazine-1,1-dioxides
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
CS236896B2 (en) 1985-05-15
FI833566A0 (fi) 1983-10-03
FI833566A (fi) 1984-04-10
DE3237473A1 (de) 1984-04-12
IL69931A (en) 1987-03-31
HUT34472A (en) 1985-03-28
EP0106214A1 (de) 1984-04-25
JPS5988482A (ja) 1984-05-22
AU1998683A (en) 1984-04-12
GB2128190B (en) 1986-07-02
DE3361437D1 (en) 1986-01-16
SU1148565A3 (ru) 1985-03-30
PT77466A (de) 1983-11-01
DK460783D0 (da) 1983-10-06
GB2128190A (en) 1984-04-26
DK460783A (da) 1984-04-10
GB8326876D0 (en) 1983-11-09
ZA837500B (en) 1985-06-26
ES526332A0 (es) 1984-11-16
PL244080A1 (en) 1985-01-16
NZ205891A (en) 1986-02-21
ES8501393A1 (es) 1984-11-16
PH20402A (en) 1986-12-12
ES531402A0 (es) 1984-12-16
ATE16807T1 (de) 1985-12-15
EP0106214B1 (de) 1985-12-04
KR840006634A (ko) 1984-12-01
NO833665L (no) 1984-04-10
GR79010B (es) 1984-10-02
CA1207767A (en) 1986-07-15
PL139147B1 (en) 1986-12-31
US4533664A (en) 1985-08-06
HU190169B (en) 1986-08-28
PT77466B (de) 1986-05-07
ES8502115A1 (es) 1984-12-16
IL69931A0 (en) 1984-01-31

Similar Documents

Publication Publication Date Title
EP0002482B1 (de) 4-Hydroxy-2H-1,2-benzothiazin-3-carboxamid-1,1-dioxide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0006506B1 (de) 1,2-Dihydro-chinolin-2-on-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE69128231T2 (de) Heterozyklische Alkylamine, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen die sie enthalten
EP0263352A1 (de) Neue Imidazo-benzoxazinone, ihre Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2628189A1 (de) 3-phenylindoline, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0185909B1 (de) 5-Alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3884007T2 (de) Arylpiperazinylalkylenphenylheterocyclische Verbindungen.
DE2541832A1 (de) Verfahren zur herstellung von n-substituierten 3,4-dihydro-2-subst.-3 bzw. 4-oxo-2h-1,2-benzothiazin-4- bzw. 3-carboxamid-1,1-dioxiden
EP0409048B1 (de) Aminoalkylsubstituierte 2-Aminothiazole und diese enthaltende therapeutische Mittel
DE2150686A1 (de) 6-amino-uracil-5-carbonsaeurethioamide
DD262230A5 (de) Verfahren zur herstellung neuer derivate von 4,5-dihydro-oxazolen
DD215549A5 (de) Verfahren zur herstellung neuer 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxide
CH631454A5 (de) Verfahren zur herstellung von basisch substituierten xanthinderivaten.
EP0072961B1 (de) 1-Phenylindazol-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3135250A1 (de) Tricyclische thiazolyloxamate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
DD202563A5 (de) Verfahren zur herstellung von 1,5-diphenylpyrazolin-3-on-verbindungen
EP0211157B1 (de) Isoxazolderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutischen Präparate
DE3017977A1 (de) Neue substituierte 2(3h)-benzothiazolone
DE69709869T2 (de) BENZO[g]CHINOLIN DERIVATE
DE2435381C2 (de) 8-(2-Dimethylaminoäthyl)-3-oxo-4-phenyl-1-thia-4,8-diazaspiro[4.5]decan und seine Salze mit Säuren, Verfahren zu ihrer Herstellung und deren Verwendung in Arzneipräparaten
CH494243A (de) Verfahren zur Herstellung von 5-Nitrothiazol-Derivaten
DD253616A5 (de) Verfahren zur herstellung von neuen pleunromutilinderivaten
EP0250436B1 (de) Mehrfach substituierte pyridin-1-oxide, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
EP0110298A1 (de) Acridanon-Derivate
DE3701737A1 (de) 1h-pyrido-(2,3-b)(1,4)-thiazine zur therapeutischen behandlung